Editas Medicine, Inc.

NASDAQ:EDIT

5 (USD) • At close July 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 1.13560.0495.3362.8879.8516.5360.0426.3626.77112.4696.1970.3796.49911.41962.84110.7495.72312.2843.8482.332.0696.11914.5197.3723.9273.6676.2823.0970.6820.8980.9623.3880.8050.7920.670.16700
Cost of Revenue 1.4091.4661.5141.541.5441.5771.6041.598000000000000032.718032.71800000000000000
Gross Profit -0.27458.5833.8221.3478.3074.959-1.5624.7646.77112.4696.1970.3796.49911.41962.84110.7495.72312.2843.8482.332.069-26.59914.519-25.3463.9273.6676.2823.0970.6820.8980.9623.3880.8050.7920.670.16700
Gross Profit Ratio -0.2410.9760.7160.4670.8430.759-37.190.7491111111111111-4.3471-3.43811111111111100
Reseach & Development Expenses 47.37868.095.33629.77937.80451.99841.32643.65937.97637.55229.26533.75341.93761.50533.91628.00734.5734.78922.70223.56515.84219.19517.44332.71821.326.42420.39617.31819.02126.83510.83210.438.8825.8263.857.2821.8882.395
General & Administrative Expenses 19.33914.45514.98717.20223.00817.98416.23616.93719.54516.52616.18522.02721.44515.78819.93614.08117.76916.91715.73414.41417.48913.17713.33414.31114.18613.68512.63511.89412.28813.04711.29512.1589.7627.3394.2023.2813.2732.793
Selling & Marketing Expenses 00000000000000000000000000000000000000
SG&A 19.33914.45514.98717.20223.00817.98416.23616.93719.54516.52616.18522.02721.44515.78819.93614.08117.76916.91715.73414.41417.48913.17713.33414.31114.18613.68512.63511.89412.28813.04711.29512.1589.7627.3394.2023.2813.2732.793
Other Expenses 0.006-0.01435.176-0.007-1.5841.2890.0010.235-0.234-0.3250.019-0.5090.0212.853-1.3967.1757.3330.008-0.033-0.068-0.044-0.003-0.0040.1540.1820.1290.1960.1220.14-0.0350.0030.005-0.03-0.2260.021-37.141-0.099-0.206
Operating Expenses 66.71782.54555.49946.98160.81269.98257.56260.59657.52154.07845.4555.7863.38277.29353.85242.08852.33951.70638.43637.97933.33132.37230.77747.02935.48640.10933.03129.21231.30939.88222.12722.58818.64413.1658.05210.5635.1615.188
Operating Income -66.991-23.962-45.019-44.094-50.961-63.446-57.52-54.234-50.75-41.609-39.253-55.401-56.883-65.8748.989-31.339-46.616-39.422-34.588-35.649-31.262-26.253-16.258-39.657-31.559-36.442-26.749-26.115-30.627-38.984-21.165-19.2-17.839-12.373-7.382-10.396-5.161-5.188
Operating Income Ratio -59.023-0.399-8.437-15.273-5.173-9.707-1,369.524-8.525-7.495-3.337-6.334-146.177-8.753-5.7690.143-2.916-8.145-3.209-8.989-15.3-15.11-4.29-1.12-5.379-8.036-9.938-4.258-8.432-44.908-43.412-22.001-5.667-22.16-15.622-11.018-62.25100
Total Other Income Expenses Net 5.0415.0885.144-0.0071.9252.7081.7940.7810.235-0.3250.019-0.5090.0212.853-1.3967.1757.3330.008-0.033-0.068-0.044-0.003-0.0040.1540.1820.1290.1960.1220.14-0.0350.0030.005-0.03-0.2260.021-37.141-0.099-0.206
Income Before Tax -61.95-18.874-45.019-40.29-49.036-60.738-55.726-53.453-50.515-41.436-39.082-55.256-56.728-62.4997.819-23.572-37.724-37.77-32.941-33.786-29.249-25.054-15.238-38.723-30.939-36.189-26.599-26.439-31.097-39.376-21.02-19.042-17.745-12.633-7.405-47.571-5.291-5.411
Income Before Tax Ratio -54.581-0.314-8.437-13.956-4.978-9.293-1,326.81-8.402-7.46-3.323-6.307-145.794-8.729-5.4730.124-2.193-6.592-3.075-8.561-14.5-14.137-4.094-1.05-5.253-7.879-9.869-4.234-8.537-45.597-43.849-21.85-5.62-22.043-15.951-11.052-284.85600
Income Tax Expense 010.334-1.514-5.351-3.469-5.704-1.794-0.781-0.235-2.009-0.152-1.843-1.297-1.705-1.333-0.5924.976-2.419-1.68-2.692-2.729-2.085-1.024-1.41-0.438-0.712-0.4420.4460.61-0.166-0.42-0.153-0.154-0.340.0440.034-0.068-0.189
Net Income -61.95-18.874-45.019-40.29-45.567-55.034-53.932-52.672-50.28-41.436-39.082-55.256-56.728-62.4997.819-23.572-37.724-37.77-32.941-33.786-29.249-25.054-15.238-38.723-30.939-36.189-26.599-26.439-31.097-39.376-21.02-19.042-17.745-12.633-7.405-47.571-5.291-5.411
Net Income Ratio -54.581-0.314-8.437-13.956-4.626-8.42-1,284.095-8.279-7.426-3.323-6.307-145.794-8.729-5.4730.124-2.193-6.592-3.075-8.561-14.5-14.137-4.094-1.05-5.253-7.879-9.869-4.234-8.537-45.597-43.849-21.85-5.62-22.043-15.951-11.052-284.85600
EPS -0.76-0.23-0.55-0.56-0.66-0.8-0.78-0.77-0.74-0.61-0.57-0.81-0.86-10.13-0.43-0.69-0.74-0.66-0.69-0.6-0.52-0.32-0.82-0.67-0.85-0.64-0.65-0.85-1.1-0.59-0.54-0.8-0.35-0.48-3.08-0.34-1.34
EPS Diluted -0.76-0.23-0.55-0.56-0.66-0.8-0.78-0.77-0.73-0.61-0.57-0.81-0.86-10.12-0.43-0.69-0.74-0.66-0.69-0.6-0.52-0.32-0.82-0.67-0.85-0.64-0.65-0.85-1.1-0.59-0.54-0.8-0.35-0.48-3.08-0.34-1.34
EBITDA -65.582-22.496-45.019-44.094-50.961-63.446-55.916-52.636-49.192-41.609-38.063-55.401-56.883-65.8748.989-30.468-39.283-39.415-33.861-35.717-31.306-26.256-15.419-39.503-30.808-36.313-26.553-25.464-29.996-39.019-21.162-18.954-17.682-12.599-7.25-10.288-5.177-5.329
EBITDA Ratio -57.781-0.375-8.437-15.273-5.173-9.707-1,331.333-8.273-7.265-3.337-6.142-146.177-8.753-5.7690.143-2.834-6.864-3.209-8.8-15.329-15.131-4.291-1.062-5.359-7.845-9.903-4.227-8.222-43.982-43.451-21.998-5.594-21.965-15.908-10.821-61.60500